Guangdong Zhaoqing Xinghu Biotech Co., Ltd.

;.1. 1 The summary of this annual report is taken from the full text of the annual report, and investors who want to understand the details should carefully read the full text of the annual report, which is also published on the website of the Shanghai Stock Exchange and other websites designated by the CSRC.aKd1. 2 Company ProfileaKdII, key financial data and shareholder changesaKd2. 1 Main Financial DataaKdunits: RMB: RMBaKd2. 2 The top 10 shareholders' shareholdingsaKdunits:aKd2. 3 Describe the property rights and control relationship between the company and the actual controller in a block diagram aKd III, management discussion and analysis aKd 3. 1 The Board of Directors on the company's reporting period of the discussion and analysis aKd 2012, due to the domestic and foreign economic downturn and the combination of fierce market competition, the company's production and operation encountered unprecedented difficulties and challenges. First, we should not only deal with the domestic competitors low-cost to seize the market disorderly competition, but also to deal with foreign competitors low-cost dumping, the company's main products face fierce market competition, especially the taste nucleotide dsodium market competition white heat. Despite the increase in sales of major products, sales prices have continued to fall since last year, at historically low levels, resulting in a decline in gross margin. Second, the original (accessory) procurement prices are still high, labor costs, capital costs, such as rising, so that production costs and operating costs continue to rise. Third, in the development is faced with the challenge of actively promoting a number of major strategic projects and the company's transformation and upgrading development. According to the company's overall development strategy and planning, in 2012 the company focused on adjusting the industrial layout and product structure, improve the level of technology research and development, accelerate the pace of new product development, expand new market space, increase the intensity of project construction, the company's several major projects have entered the trial production or commissioning stage, related income has not yet been reflected in 2012. aKd operating income of 10.1% during the reporting period. 9.1 billion yuan, up 2. 64%。 Among them: biochemical sales revenue 3. 3 billion yuan, up 7. 58%; Food additives achieve sales revenue 4. 2.3 billion yuan, up 5. 23%; Feed additives achieve sales revenue 1. 8.2 billion yuan, down 47. 61%。 Total Profit -2. 2.5 billion yuan, down 371 percent year-on-year. 65%; Net profit attributable to the owner of the parent company -2. 02.8 billion yuan, down 331 percent year-on-year. 34%。 The main reasons for the loss: objectively, the slowdown in macroeconomic growth, industry overcapacity and disorderly competition are the main factors, especially the taste nucleotide di sodium should face domestic overcapacity, disorderly competition, but also to face the dumping of Japanese and Korean enterprises; aKd in the face of severe external environment and operational difficulties, the company's board of directors conscientiously performs its duties, scientific decision-making, strictly implements the resolutions of the shareholders' meeting, leads the management team and all staff, actively takes measures to meet the challenges, makes concerted efforts to find breakthroughs, and promotes the steady progress of production and management and various work. aKd 3. 2 Main business sub-sectors, sub-products aKd units: RMB currency: RMB aKd 3. 3 Details of significant changes in the composition of the Company's profits or the sources of profits aKd 3. 4 The Board of Directors on the future development of the company's discussion and analysis aKd (i) industry competition pattern and development trends aKd 1, 2010 the State Council issued the "Decision of the State Council on Accelerated Cultivation and Development of Strategic New Industries" plan, by 2020 the biological industry will become the pillar industry of China's national economy. The 12th Five-Year Plan for National Economic and Social Development of the People's Republic of China, issued in October 2010, and the 12th Five-Year Plan for National Economic and Social Development of the People's Republic of China issued in March 2011, state that industries such as biological and high-end equipment manufacturing should be developed in an orderly and orderly manner. The development of leading products is in line with national industrial policy and has a better prospects for sustainable development. aKd 2, from a macro point of view, the world economy will continue the low-speed growth trend, economic development from the rapid development period before the crisis into the transition adjustment period. The national macro-economy as a whole is improving, but still faces many risks and challenges, the unbalanced, uncoordinated and unsustainable problems are still outstanding, the contradiction between downward pressure on economic growth and overcapacity has intensified, the market competition is fierce, and the company's business development is facing serious challenges. aKd 3, from the perspective of industry development, China has become a large global food production, feed production and global chemical API production. aKd with the continuous upgrading of consumption, food manufacturing industry shows a trend towards high-end development, the market capacity of high-end food in further expansion, brand products market share further increased. In the next few years, food products will be towards diversification, compound convenience, nutrition and health care and other directions. aKd With the development of animal husbandry, the development momentum of feed industry in China is very rapid, and feed additives to improve the nutritional value of feed, improve feed utilization rate, promote animal production, improve animal health, improve animal product quality, improve animal production performance, reduce production costs and so on have an extremely important role. From the world, the largest amino acid market is feed additives, the use of low protein, high amino acids, high energy feed is the latest trend of the feed market, with essential amino acids as supplementary feed can bring huge production benefits to the poultry industry and pig industry. Currently, about 50 per cent of global amino acids are used in feed, 35 per cent in food and 15 per cent for medicine and cosmetics (Source: China Fermentation Industry Association). aKd API industry is located at the forefront of the Western pharmaceutical industry chain and is the foundation of the Western pharmaceutical industry. The basic feature of the world API industry is the relatively concentrated origin, many varieties, most of the single API market capacity is relatively limited. All along, the API industry has been supported by China's industrial policy. On November 27, 2001, the "Fifteenth Plan" for the Development of the Pharmaceutical Industry, issued by the former State Economic and Trade Commission, showed that API is one of the key points of the development of China's pharmaceutical industry, and efforts should be made to expand the export of chemical API, especially the export of high value-added products, and actively participate in international competition. On June 26, 2006, the National Development and Reform Commission issued the "11th Five-Year Plan" development guidance for the pharmaceutical industry on the future development of the API industry pointed out: consolidate and enhance the production advantages of China's traditional API, the introduction, digestion and absorption of foreign advanced technology and equipment, improve the production of China's API technology level; aKd 4, from the company's product process and its own development, the company's main products are using biofermentation mode of production, product structure is not rich, high input, high energy consumption, low value-added products accounted for the company's dominant position has not changed, especially in the increasingly severe market management situation, accelerate product restructuring, promote the company's transformation and upgrading development is the general trend, is the inevitable choice. aKd (ii) company development strategy aKd company adhering to the concept of "run a first-class enterprise, create a world famous brand", adhere to the implementation of the high-end industrial development strategy and the internationalization strategy of enterprise management, according to the "North And South High" strategy to adjust the product structure and industrial layout. Focus on improving independent innovation ability, promote industrial transformation and upgrading with technological innovation, improve the company's operating level with management innovation, focus on technology research and development and major project construction, further optimize the industrial layout, extend the industrial chain, enhance product competitiveness, optimize sales channels, vigorously explore domestic and foreign markets, and enhance competitiveness through scale effects to achieve the overall improvement of the company's sales and profitability. We will increase strategic investment and strategic cooperation, actively engage in emerging industries with broad market prospects and strong growth, explore ways of investment cooperation, and explore new business areas based on bold attempts and steady implementation. We will actively promote the implementation of the "going out" strategy, accelerate the implementation of the strategic deployment of industrial transfer, and urgently carry out the construction of industrial bases in the main raw material seright areas. Play the role of national technology center, realize industrial strategic transformation and upgrading, continue to lead the development of the industry, focus on building the South China bioengineering industry production and research base, South China non-ferrous metal new materials high-end industrial production and research and development base, and strive to "12th Five-Year Plan" period to achieve the goal of quadrupling sales, and strive to build Star Lake technology into China's brand-name high-quality enterprises. aKd (iii) Business Plan aKd 2013, the company to improve product profitability and asset operating capacity as the core, marketing as the traction, to safety production as the premise, to save energy and consumption as the basis, to production, supply and marketing linkage and budget management as a means to benchmark management, cost control and performance appraisal as the grasping hand To build and manage the promotion of the support, closely around the transformation and upgrading, innovation and development of the main line of work, focus on management and management to improve efficiency, key projects to achieve production standards, product restructuring results, to achieve independent innovation, operation control, resource concentration and sustained profitability of the effective promotion, grasp the implementation of the work, overcome difficulties, reduce costs, increase efficiency, promote the sustainable, stable and scientific development of enterprises. In 2013, the company strived to turn a profit. aKd 3. 5 Risks that may be faced aKd 1, industrial policy risks. The company's main products are starch as raw materials, the use of bioenzyme catalyst conversion technology, microbial fermentation technology and other modern bioengineering technology and supplemented by physical and chemical methods of fermentation products, although the company's main technology and products by the national and local industrial policies to encourage and protect, but if the country or local adjustment of relevant industrial policies, may have a certain impact on the company's production and operation. aKd countermeasures and measures: pay close attention to the economic situation at home and abroad, carefully analyze national macroeconomic policies and industrial policies, innovate the development model, improve independent innovation ability, grasp the key points, strengthen management, adjust industrial layout, adjust product structure, strive to reduce production costs, while giving full play to the role of new production projects, expand sales, and continuously improve the company's profitability and sustainable development capabilities. aKd 2, food quality and safety risks. The company has a strict quality control system, since its inception has not occurred food safety liability accidents, but if the industry's systematic food safety quality incidents and other unforeseen problems, may cause a certain negative impact on the company's terminal sales and produce compensation risk. aKd countermeasures and measures: establish and improve the long-term mechanism of product quality and safety risks, strengthen the sense of responsibility, strictly implement the Food Safety Law, Product Quality Law and other laws and regulations, fully implement the main responsibility of product quality and safety, and eliminate safety hazards. Solidly grasp the quality certification work, and actively apply for high-end market quality certification, to maintain the good operation of the quality certification system, to ensure product quality. aKd 3, safety and environmental risks. With the further improvement of the national environmental requirements, as well as the company's new projects gradually put into production, national security and environmental protection policies and supervision continue to strengthen, increasing the company's safety and environmental pressure. aKd countermeasures and measures: based on the standardization of safe production construction, with the focus on standard management, with safety education and training, hidden trouble detection and management, risk prevention and management as a means, and actively introduce.